Author

Xuesong Wang

Leiden UniversityORCID 0000-0002-3293-4786Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xuesong Wang1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:long-read sequencing· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Agnieszka B. WegrzyniD· 1 shared Amy C. HarmsiD· 1 shared Annelien J.M. ZweemeriD· 1 shared Bob van de WateriD· 1 shared Christine Hoegen· 1 shared Erik H.J. DaneniD· 1 shared Hanneke LeegwateriD· 1 shared Luojiao HuangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agnieszka B. WegrzynORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multi-omics characterization of breast cancer metabolism identifies new metabolic targets

Hanneke Leegwater, Xiaobing Zhang, Luojiao Huang, Christine Hoegen, Xuesong Wang, Agnieszka B. Wegrzyn, Thomas Hankemeier, Bob van de Water, Erik H.J. Danen, Annelien J.M. Zweemer, Amy C. Harms, Sylvia E. Le Dévédec

This study identifies metabolic targets in breast cancer by analyzing multi-omics data from cell lines, revealing subtype-specific dependencies and potential drug targets.

bioRxiv · Mar 9, 2026 · PreprintCancer Biology